Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data.

Min Seo KiDawoon JeongHee-Yeon KangHongjo ChoiHojoon SohnYoung Ae Kang

Published in: BMJ open respiratory research (2023)

In Korea, prescription of FDC to treat newly diagnosed patients with DS TB improved patient's treatment completion. Use of FDC did not increase the risks of TB recurrence or development of drug resistance.

Keyphrases

mycobacterium tuberculosis
newly diagnosed
case report
pulmonary tuberculosis
adverse drug
hiv aids
electronic health record
quality improvement
human health
risk assessment
machine learning
combination therapy
human immunodeficiency virus
hepatitis c virus
replacement therapy